The Preventive Polypill — Much Promise, Insufficient Evidence

Abstract

The rapidly increasing global burdens of cardiovascular disease and diabetes call for interventions that have a population-wide effect, as well as interventions that identify and protect individual patients who have a high risk of major adverse events. Such actions are especially needed in low-income and middle-income countries, which can ill afford the huge losses in human and financial resources that will result from unchecked development of clinical disease.¹